Mostrar el registro sencillo del ítem

dc.contributor.author
Malfitano, Christiane  
dc.contributor.author
Andrade Barboza, Catarina de  
dc.contributor.author
Mostarda, Cristiano  
dc.contributor.author
Palma, Renata Kelly da  
dc.contributor.author
Santos, Camila Paixão dos  
dc.contributor.author
Rodrigues, Bruno  
dc.contributor.author
Ferreira Freitas, Sarah Cristina  
dc.contributor.author
Belló Klein, Adriane  
dc.contributor.author
Llesuy, Susana Francisca  
dc.contributor.author
Irigoyen, Maria Cláudia  
dc.contributor.author
De Angelis, Kátia  
dc.date.available
2017-12-15T18:55:49Z  
dc.date.issued
2014-10  
dc.identifier.citation
De Angelis, Kátia; Irigoyen, Maria Cláudia; Llesuy, Susana Francisca; Belló Klein, Adriane; Ferreira Freitas, Sarah Cristina; Rodrigues, Bruno; et al.; Diabetic hyperglycemia attenuates sympathetic dysfunction and oxidative stress after myocardial infarction in rats; BioMed Central; Cardiovascular Diabetology; 13; 131; 10-2014; 1-9  
dc.identifier.issn
1475-2840  
dc.identifier.uri
http://hdl.handle.net/11336/30795  
dc.description.abstract
Background: Previous research has demonstrated that hyperglycemia may protect the heart against ischemic injury. The aim of the present study was to investigate the association between hyperglycemia and myocardial infarction on cardiovascular autonomic modulation and cardiac oxidative stress profile in rats. Male Wistar rats were divided into: control (C), diabetic (D), myocardial infarcted (MI) and diabetic infarcted rats (DMI). Methods: Diabetes was induced by streptozotocin (STZ, 50 mg/Kg) at the beginning of the protocol and MI was induced by left coronary occlusion 15 days after STZ. Thirty days after streptozocin-induced diabetes, cardiovascular autonomic modulation was evaluated by spectral analysis, and oxidative stress profile was determined by antioxidant enzyme activities and superoxide anion, together with protein carbonylation and redox balance of glutathione (GSH/GSSG). Results: The diabetic and infarcted groups showed decreased heart rate variability and vagal modulation (p < 0.05); however, sympathetic modulation decreased only in diabetic groups (p < 0.05). Sympatho/vagal balance and vascular sympathetic modulation were increased only in the MI group (p < 0.05). Diabetes promoted an increase in catalase concentration (p < 0.05). Glutathione peroxidase activity was increased only in DMI when compared to the other groups (p < 0.05). Superoxide anion and protein carbonylation were increased only in MI group (p < 0.05). Cardiac redox balance, as evaluated by GSH/GSSG, was lower in the MI group (p < 0.05). Conclusions: These data suggest that hyperglycemia promotes compensatory mechanisms that may offer protection against ischemia, as demonstrated by increased antioxidants, decreased pro-oxidants and protein damage, possibly related to the improvements in both redox balance and sympathetic modulation to the heart.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
BioMed Central  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/  
dc.subject
Autonomic Modulation  
dc.subject
Oxidative Stress  
dc.subject
Diabetic Hyperglycemia  
dc.subject
Myocardial Infarction  
dc.subject.classification
Otras Ciencias Biológicas  
dc.subject.classification
Ciencias Biológicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
Diabetic hyperglycemia attenuates sympathetic dysfunction and oxidative stress after myocardial infarction in rats  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2017-12-15T14:53:54Z  
dc.journal.volume
13  
dc.journal.number
131  
dc.journal.pagination
1-9  
dc.journal.pais
Reino Unido  
dc.journal.ciudad
Londres  
dc.description.fil
Fil: Malfitano, Christiane. Universidade Nove de Julho ; Brasil  
dc.description.fil
Fil: Andrade Barboza, Catarina de. Universidade São Judas Tadeu; Brasil  
dc.description.fil
Fil: Mostarda, Cristiano. Universidade Federal do Maranhão ; Brasil. Universidade de Sao Paulo; Brasil  
dc.description.fil
Fil: Palma, Renata Kelly da. Universidade Nove de Julho ; Brasil  
dc.description.fil
Fil: Santos, Camila Paixão dos. Universidade Nove de Julho ; Brasil  
dc.description.fil
Fil: Rodrigues, Bruno. Universidade São Judas Tadeu; Brasil  
dc.description.fil
Fil: Ferreira Freitas, Sarah Cristina. Universidade Nove de Julho ; Brasil  
dc.description.fil
Fil: Belló Klein, Adriane. Universidade Nove de Julho ; Brasil. Universidade Federal do Rio Grande do Sul; Brasil  
dc.description.fil
Fil: Llesuy, Susana Francisca. Universidade Nove de Julho ; Brasil. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Bioquímica y Medicina Molecular. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Bioquímica y Medicina Molecular; Argentina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Química Analítica y Fisicoquímica. Cátedra de Química General e Inorgánica; Argentina  
dc.description.fil
Fil: Irigoyen, Maria Cláudia. Universidade de Sao Paulo; Brasil  
dc.description.fil
Fil: De Angelis, Kátia. Universidade Nove de Julho ; Brasil  
dc.journal.title
Cardiovascular Diabetology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198704/  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1186/s12933-014-0131-x  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://cardiab.biomedcentral.com/articles/10.1186/s12933-014-0131-x